Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord

The Journal of Physiology
Amyaouch BradaïaJérôme Trouslard

Abstract

Using whole cell voltage clamp recordings from lamina X neurones in rat spinal cord slices, we investigated the effect of glycine transporter (GlyT) antagonists on both glycinergic inhibitory postsynaptic current (IPSCs) and glutamatergic excitatory postsynaptic current (EPSCs). We used ORG 24598 and ORG 25543, selective antagonists of the glial GlyT (GlyT1) and neuronal GlyT (GlyT2), respectively. In rats (P12-P16) and in the presence of kynurenic acid, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and bicuculline, ORG 24598 and ORG 25543 applied individually at a concentration of 10 microm induced a mean inward current of -10/-50 pA at -60 mV and increased significantly the decay time constants of miniature (mIPSCs), spontaneous (sIPSCs) and electrically evoked glycinergic (eIPSCs) inhibitory postsynaptic currents. ORG 25543, but not ORG 24598, decreased the frequency of mIPSCs and sIPSCs. Replacing extracellular sodium with N-methyl-d-glucamine or superfusing the slice with micromolar concentrations of glycine also increased the decay time constant of glycinergic IPSCs. By contrast, the decay time constant, amplitude and frequency of miniature GABAergic IPSCs recorded in the presence of strychnine were not affected by ORG 2459...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J GuastellaN Davidson
Jun 29, 1992·FEBS Letters·Q R LiuN Nelson
Nov 1, 1983·The Journal of Comparative Neurology·R L NahinG J Giesler
Apr 1, 1996·Journal of Neurophysiology·M J TitmusD S Faber
Nov 15, 1996·The Journal of Physiology·A BordeyJ Trouslard
Mar 1, 1996·Trends in Neurosciences·M V Jones, G L Westbrook
Dec 5, 1997·Brain Research. Molecular Brain Research·I PoyatosF Zafra
May 20, 1998·Journal of Neurophysiology·B X GaoL Ziskind-Conhaim
Nov 18, 1998·Journal of Neurophysiology·J H SingerA J Berger
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·R BergeronR W Greene
Nov 11, 1999·Pflügers Archiv : European journal of physiology·Y OkuD W Richter
Mar 30, 2001·The Journal of Biological Chemistry·A GeerlingsC Aragón
Apr 25, 2001·Journal of Neuroscience Research·A Gadea, A M López-Colomé
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·P Legendre
Jul 17, 2001·Bioorganic & Medicinal Chemistry Letters·A BrownG Walker
Aug 10, 2001·Journal of Medicinal Chemistry·W L CaulfieldH Sundaram
Jun 28, 2003·Science·Seifollah AhmadiHanns Ulrich Zeilhofer

❮ Previous
Next ❯

Citations

Jun 1, 2005·Trends in Pharmacological Sciences·Carmen Aragón, Beatriz López-Corcuera
May 25, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Long-Hua ZhangTian-Le Xu
Jan 20, 2011·The Journal of Biological Chemistry·Esperanza JiménezBeatriz López-Corcuera
Aug 22, 2008·Journal of Neurophysiology·Rebecca MongeonJulia E Dallman
Feb 3, 2012·Physiological Reviews·Hanns Ulrich ZeilhoferGonzalo E Yévenes
Jul 18, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marco Beato
Mar 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pierre F Apostolides, Laurence O Trussell
Jun 26, 2014·Trends in Pharmacological Sciences·Robert J VandenbergMacdonald J Christie
Jan 3, 2016·Neurochemistry International·Robert J VandenbergRenae M Ryan
Dec 24, 2015·Frontiers in Cellular Neuroscience·Balázs Pál
Jan 26, 2010·Brain Research Reviews·Volker Eulenburg, Jesús Gomeza
Sep 19, 2008·IUBMB Life·Francisco Zafra, Cecilio Giménez
Jan 13, 2006·British Journal of Pharmacology·Leslie Iversen
Sep 24, 2010·British Journal of Pharmacology·Hyo-Jin JeongChristopher W Vaughan
Jun 14, 2005·Biophysical Journal·Karin R AubreyJohn D Clements
Jun 14, 2005·Trends in Biochemical Sciences·Volker EulenburgJesús Gomeza
Jan 8, 2015·Frontiers in Neural Circuits·Jana NerlichIvan Milenkovic
Apr 28, 2009·Pharmacology & Therapeutics·Toshihiro DohiNorimitsu Morioka
Jan 30, 2018·Frontiers in Molecular Neuroscience·Anja ArmbrusterVolker Eulenburg
Jun 15, 2007·Neuroreport·Riad SeddikJérôme Trouslard
Dec 15, 2007·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Katsuya MoritaToshihiro Dohi
Oct 9, 2008·Neuroreport·Xin-Jun ZhangXiong-Li Yang
May 2, 2008·The Journal of Pharmacology and Experimental Therapeutics·Katsuya MoritaToshihiro Dohi
Jul 15, 2011·Pharmacological Reviews·Anders S KristensenUlrik Gether
Apr 16, 2019·Pain·Volodymyr KrotovNana Voitenko
Aug 24, 2017·Alcoholism, Clinical and Experimental Research·Bo SöderpalmMia Ericson
Jan 19, 2006·Biochemical Society Transactions·H BetzV Eulenburg
Aug 10, 2017·Cellular and Molecular Life Sciences : CMLS·Hanns Ulrich ZeilhoferGonzalo E Yévenes
Sep 25, 2014·Biomedit︠s︡inskai︠a︡ khimii︠a︡·V N Nikandrov, T V Balashevich
Nov 23, 2017·Frontiers in Cellular Neuroscience·Volodymyr KrotovNana Voitenko
Jul 28, 2018·Frontiers in Molecular Neuroscience·Braulio MuñozLuis G Aguayo
May 22, 2020·British Journal of Pharmacology·Loreto San MartinLuis G Aguayo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.